These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12920388)

  • 21. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
    Papakostas GI; Nelson JC; Kasper S; Möller HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):122-7. PubMed ID: 17719752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.
    Harmer CJ; Shelley NC; Cowen PJ; Goodwin GM
    Am J Psychiatry; 2004 Jul; 161(7):1256-63. PubMed ID: 15229059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.
    Penttilä J; Syvälahti E; Hinkka S; Kuusela T; Scheinin H
    Psychopharmacology (Berl); 2001 Apr; 154(4):343-9. PubMed ID: 11349386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
    Murphy SE; Yiend J; Lester KJ; Cowen PJ; Harmer CJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):169-79. PubMed ID: 18752726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
    Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G
    J Psychopharmacol; 2012 May; 26(5):663-9. PubMed ID: 22223618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting effects of citalopram and reboxetine on waking salivary cortisol.
    Harmer CJ; Bhagwagar Z; Shelley N; Cowen PJ
    Psychopharmacology (Berl); 2003 Apr; 167(1):112-4. PubMed ID: 12605289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M; Wistedt B
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
    Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
    Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
    Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ
    Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors].
    Rubio G; San L; López-Munoz F; García-García P; Alamo C
    Actas Esp Psiquiatr; 2003; 31(6):315-24. PubMed ID: 14639507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.